Richard Totten

Richard Totten serves as a key procurement lead within the W6QK Acc-apg Natick facility under the Department of the Army, supporting the U.S. Army Combat Capabilities Development Command’s mission to advance soldier systems through research-driven acquisitions. He manages a portfolio of technical service contracts focused on the development and integration of advanced battlefield equipment, including flame-resistant textiles, life-sustaining medical devices, and mission-critical instrumentation. His work directly enables the modernization of individual soldier systems by securing innovative solutions in physical and engineering sciences, ensuring warfighters are equipped with next-generation capabilities for high-threat environments. Totten maintains consistent contracting relationships with EPERNAY DESIGN & CONSTRUCTION LLC and TEVET LLC, both of which provide specialized engineering, prototyping, and technical services aligned with Army R&D priorities. These partnerships reflect a pattern of sustained collaboration with niche vendors capable of delivering rapid-cycle, high-precision technical solutions under stringent military specifications. His procurement approach emphasizes technical excellence and mission alignment over volume, favoring established contractors with proven expertise in defense-critical R&D domains. His contracting activity reflects a strong preference for open competition, with 95.5% of awards issued without set-asides, indicating a focus on technical merit and capability over socioeconomic categorization. While small business participation remains limited—accounting for just 3.0% under total small business set-asides and 1.5% under Women-Owned Small Business programs—his approach prioritizes mission-critical performance, with socioeconomic preferences applied only where demonstrably aligned with technical requirements. Totten’s procurement focus is heavily concentrated in NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences), which accounts for nearly 68% of his activity, supplemented by 541712 and 541714 for non-biotech and biotech R&D, respectively. He routinely acquires advanced materials development, human performance optimization systems, and field-deployable diagnostic instrumentation, demonstrating deep expertise in defense-oriented scientific and technical services.